Immutep Limited, Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia; ABN: 90 009 237 889 Immutep and Monash University Secure Further ARC Linkage Projects Funding for LAG-3 Research SYDNEY, AUSTRALIA – 14 October 2026 – Immutep Limited (ASX: IMM; NASDAQ: IMMP)...
Immutep & Monash Secure Further ARC Funding for LAG-3
Filed with ASX · · 3 pages · English
Release
Earlier from Immutep
- Immutep Regains Compliance with Nasdaq
- Audit and Risk Committee Update
- Final Director's Interest Notice - P Meyers
- Notification of cessation of securities - IMM
- Resignation of Non-Executive Director
Later from Immutep
- 2026 Annual General Meeting and Key Dates
- Late-Breaking Abstract on IMP761 to be presented at ACR 2026
- Quality of Life Data from EFTISARC-NEO presented at ESMO
- Annual Report filed on Form 20-F
- Annual Report to shareholders
Follow Immutep into a list and get an email when it puts out news.
Follow Immutep